Senescent support cells cluster at human pancreatic tumor edges
An observational study of tumors from 60 surgical patients mapped these connective-tissue cells and linked their abundance to poorer prognosis.
Our read
Mechanisms- Studied:
- Cross-sectional study of 60 patients with pancreatic ductal adenocarcinoma
- What changed:
- Senescent support cells accumulated preferentially near pancreatic tumor edges
- The catch:
- Sampling only surgically removed tumors excluded patients who did not undergo surgery
- In the record:
- The 78th paper on chemotherapy with results in people; 315 on record in all. Its result on cellular senescence agrees with all 11 other findings on record.
Editor of record: Boris Djordjevic · AgingResearch.News
Researchers studied pancreatic ductal adenocarcinoma tissue from 60 patients who underwent surgery at Kobe University Hospital in Japan. This retrospective observational study used staining and gene-activity mapping to locate fibroblasts, cells that form connective tissue. Twenty-four patients had not received chemotherapy before surgery; 36 had.
Senescent fibroblasts, cells in a state of halted division, accumulated preferentially near the visible tumor edge. Their abundance was associated with poorer prognosis. Tumors from patients who had received chemotherapy contained more senescent fibroblasts, including within the tumor core. Gene-activity mapping also suggested that these cells exchanged signals with neighboring cells.
Why it matters
The work connects cell senescence, a process relevant to aging, with pancreatic cancer biology. The authors suggest that substances released by senescent fibroblasts could influence tumor progression.
Caveats
The retrospective comparisons cannot establish that these cells caused poorer prognosis or that chemotherapy caused their accumulation. The findings concern surgically removed tumors, not all people with pancreatic cancer.
- Chemotherapy
- Cellular senescence
- Senescence-associated secretory phenotype (SASP)
- Pancreatic ductal adenocarcinoma
- Cancer
- Humans
The paper
Kobe University; The University of Osaka
Cellular and Molecular Gastroenterology and Hepatology, Jan 1, 2026, Open access
Comments
Be the first to comment.